Author Details

Cybulska-Stopa, Bożena, Poland

  • Vol 14, No 2 (2018) - CASE REPORT
    Patient with stage IV melanoma with BRAF mutation — immunotherapy or BRAF and MEK inhibitors?
    Abstract  PDF
  • Vol 16, No 4 (2020) - ORIGINAL ARTICLE
    Immunotherapy or targeted therapy as first-line treatment of patients with advanced/metastatic melanoma with the BRAF mutation — a single-center analysis
    Abstract  PDF
  • Vol 16, No 4 (2020) - GUIDELINES FOR DIAGNOSTIC AND THERAPEUTIC MANAGEMENT
    Cutaneous melanoma
    Details  PDF

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl